This is a federal delivery order contract awarded by the Defense agency Medical Supply Chain to the prime contractor Glaxosmithkline, LLC for the supply of the antiviral medication zanamivir for inhalation. The contract has a ceiling value of $325,166.40 and was awarded on a firm fixed price basis with no set-aside designation. Glaxosmithkline has provided a range of pharmaceutical products and services to various U.S. government agencies through federal contracts and grants, including influenza vaccines, COVID-19 treatments, and other antivirals. The delivery order is part of a larger $4.6 million indefinite delivery vehicle contract Glaxosmithkline holds with the Defense Logistics Agency Troop Support to provide the antiviral medication zanamivir. The contract supports disease prevention efforts and drug stockpiling initiatives for U.S. government agencies.